246 related articles for article (PubMed ID: 10835983)
1. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
Czech N; Brenner W; Kampen WU; Henze E
Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
[No Abstract] [Full Text] [Related]
2. [Positron emission tomography (PET) in clinical oncology [Part III]].
Cabrera Villegas A; García Velloso MJ; Gámez Cenzano C
Rev Esp Med Nucl; 2002 Jul; 21(4):304-20; quiz 321-3. PubMed ID: 12206748
[No Abstract] [Full Text] [Related]
3. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effective PET scans in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909
[TBL] [Abstract][Full Text] [Related]
5. [Positron-emission tomography in oncology].
Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F
Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150
[TBL] [Abstract][Full Text] [Related]
6. [Cost-effective PET investigations in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O
Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917
[TBL] [Abstract][Full Text] [Related]
7. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
[TBL] [Abstract][Full Text] [Related]
8. Clinical role of positron emission tomography in oncology.
Bomanji JB; Costa DC; Ell PJ
Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of (18)F-FDG in oncology.
Nabi HA; Zubeldia JM
J Nucl Med Technol; 2002 Mar; 30(1):3-9; quiz 10-1. PubMed ID: 11948260
[TBL] [Abstract][Full Text] [Related]
10. [Positron-emission tomography in oncology].
Carreras Delgado JL
An R Acad Nac Med (Madr); 1997; 114(2):445-70; discussion 470-8. PubMed ID: 9412252
[No Abstract] [Full Text] [Related]
11. Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Kubota K; Matsuno S; Morioka N; Adachi S; Koizumi M; Seto H; Kojo M; Nishioka S; Nishimura M; Yamamoto H
Ann Nucl Med; 2015 Jun; 29(5):431-41. PubMed ID: 25812534
[TBL] [Abstract][Full Text] [Related]
12. [A proposal for the rational use of the PET in oncology].
Borrego Dorado I; Vázquez Albertino R
Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of PET in oncology.
Rohren EM; Turkington TG; Coleman RE
Radiology; 2004 May; 231(2):305-32. PubMed ID: 15044750
[TBL] [Abstract][Full Text] [Related]
14. [Clinical indications for PET in oncology].
von Gumppenberg RM; Strauss LG
Schweiz Rundsch Med Prax; 1993 Aug; 82(34):919-23. PubMed ID: 8372297
[TBL] [Abstract][Full Text] [Related]
15. PET/CT in oncology: for which tumours is it the reference standard?
Collins CD
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S77-87. PubMed ID: 17921085
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of gallium in oncology.
Johnston GS
Int J Nucl Med Biol; 1981; 8(4):249-55. PubMed ID: 6948781
[No Abstract] [Full Text] [Related]
17. Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging.
Sanz-Viedma S; Torigian DA; Parsons M; Basu S; Alavi A
Rev Esp Med Nucl; 2009; 28(3):159-66. PubMed ID: 19558958
[No Abstract] [Full Text] [Related]
18. [Positron emission tomography in oncology].
Hatazawa J; Higuchi I; Nakamura H
Gan To Kagaku Ryoho; 2003 Jun; 30(6):748-54. PubMed ID: 12852339
[TBL] [Abstract][Full Text] [Related]
19. The applications of PET in clinical oncology.
Strauss LG; Conti PS
J Nucl Med; 1991 Apr; 32(4):623-48; discussion 649-50. PubMed ID: 2013803
[TBL] [Abstract][Full Text] [Related]
20. [Positron emission tomography (PET) in clinical oncology. Part II].
Cabrera Villegas A; Gámez Cenzano C; Martín Urreta JC
Rev Esp Med Nucl; 2002 Apr; 21(2):131-47; quiz 149-51. PubMed ID: 11879626
[No Abstract] [Full Text] [Related]
[Next] [New Search]